期刊文献+

结直肠癌组织多不饱和脂肪酸异常的临床病理意义 被引量:4

Clinicopathological significance of abnormal metabolism of polyunsaturated fatty acids in colorectalcancer tissue
原文传递
导出
摘要 目的探讨结直肠癌组织中多不饱和脂肪酸(PUFA)的含量与临床病理因素的关系,评价PUFA的含量在结直肠癌预后判断中的价值。方法新鲜冰冻的肿瘤组织取自2010年12月至2011年3月解放军总医院普通外科行结直肠癌切除术的82例患者,其中男51例、女31例;年龄29—83岁,中位年龄60.2岁。应用气相色谱毛细管层析法检测标本中各PUFA的含量并进行常规病理检查及免疫组织化学检测。按各脂肪酸成分及相关脂肪酸比值,分别从性别、年龄、肿瘤发生位置、病理特征、转移情况及患者血管内皮生长因子(VEGF)、Ki-67及P53肿瘤指标不同表达程度等方面比较组织中各PUFA含量差异。采用t检验、方差分析检验比较不同临床病理情况下的各PUFA含量差异。结果年龄≥60岁患者(n=44)中花生四烯酸(AA)含量低于年龄〈60岁患者(n=38)(0.12%±0.06%比0.17%±0.09%,P:0.045)。肿瘤大小〈5cm(n=42)的组织中二十碳五烯酸(EPA)含量高于肿瘤≥15cm者(n=40)(0.29%±0.13%比0.20%±0.14%,P=0.030),而ω-6/ω-3PUFA则低(10.8±2.6比13.2±6.4,P=0.031)。分化程度不同的患者肿瘤组织中亚油酸含量和AA/ω-3PUFA差异均有统计学意义(P=0.013、0.027),分化程度低者亚油酸含量最高(19.9%±6.3%)而AA/ω-3PUFA最低(4.1±2.0)。在VEGF阳性肿瘤患者组织中亚油酸含量高于阴性者(16.2%±3.7%比13.9%±2.7%,P=0.009),而AA/ω-3PUFA、AA/ω-6PUFA、AA/亚油酸均低(5.0±1.8比6.7±3.3.0.30±0.09比0.34±0.09,0.50±0.21比0.61±0.21,P=0.004、0.038、0.030)。在Ki-67不同表达程度的患者肿瘤组织中亚油酸含量差异有统计学意义(P=0.048),Ki-67阴性者亚油酸含量最高(22.5%±10.1%)。各脂肪酸含量在性别、临床分期、淋巴结转移及P53指标中差异均无统计学意义(均P〉0.05)。结论肿瘤组织中PUFA的含量与临床病理指标有关联,并在一定程度上可以反映出肿瘤的恶性程度及预后等情况。 Objective To explore the relationship between different tissue levels of polyunsaturated fatty acid (PUFA) and the elinieopathologic parameters in eolorectal carcinoma (CRC) and evaluate their prognostic significance. Methods Fresh frozen malignant tissue was obtained from 82 eolorectal cancer patients at PLA general Hospital from December 2010 to March 2011. The immunohistochemieal results were obtained for vascular endothelial growth factor(VEGF) , P53 and Ki-67. The relationship between the PUFA level and such clinicopathological profiles as age, gender, location, differentiation degree, TNM (tumor, node and metastasis) stage, VEGF, Ki-67 and P53 was analyzed. Results Tissue level of araehidonic acid (AA) in patients aged over 60 years (n =44) was significantly lower than those under 60 years (n = 38) (0. 12%±0.06% vs 0. 17%±0. 09% , P =0. 045). In patients with tumor size 〈 5 cm (n =42), tissue level of EPA was significantly higher (0. 29% ± 0. 13% vs 0. 20% ±0. 14% , P = 0. 030) while ω-6/ω-3 PUFA lower ( 10. 8± 2. 6 vs 13.2 ± 6. 4, P = 0. 031 ). Significant statistical difference existed in tissue level of LA, AA/ω-3 PUFA in different differentiation degrees( P =0. 013,0.027 ). Tissue level of linoleie acid (LA) in poorly differentiated tumor was the highest (19. 9%±6. 3% ) while AA/ω-3 PUFA the lowest(4. 1 ± 2. 0, P 〈 0. 05 ). Tissue level of LA was higher in VEGF-positive tumors than those in VEGF- negative counterparts ( 16. 2% ± 3.7% vs 13.9% ± 2. 7%, P = 0. 009 ) while the ratios AA/ω-3 PUFA, AAfoJ-6 PUFA, AA/LA in VEGF-positive tumors were lower than those in VEGF-negative counterparts (5.0±1.8 vs 6. 7 ± 3. 3 , 0. 30 ± 0. 09 vs 0. 34 ± 0. 09 , 0.50±0.21 vs0.61±0.21, P=0.004, 0.038, 0. 030). In Ki-67 negative LA was highest ( 22. 5% ± 10. 1% , P = 0. 048 ). No significant differences existed in the level of PUFA among the gender, the clinicopathological stage, lymph node metastasis and groups with differential expressions of P53 ( all P 〉 0.05 ). Conclusions The tissue levels of PUFA are somewhat correlated with the clinicopathologic parameters of CRC. And the prognosis of CRC may be evaluated through the test of PUFA.
出处 《中华医学杂志》 CAS CSCD 北大核心 2013年第20期1550-1554,共5页 National Medical Journal of China
基金 首都特色临床医学应用发展基金(Z101102050210004)
关键词 结直肠肿瘤 脂肪酸类 不饱和 血管内皮生长因子类 KI-67抗原 基因 p53 Colorectal neoplasms Fatty acids, unsaturated Vascular endothelial growth factors Ki-67 antigen Genes,p53
  • 相关文献

参考文献21

  • 1朱元民,刘玉兰.提高早期结直肠癌诊断率所面临的选择及问题[J].中华医学杂志,2011,91(41):2881-2882. 被引量:11
  • 2Cai F, Dupertuis YM, Pichard C. Role of polyunsaturated fatty acids and lipid peroxidation on colorectal cancer risk and treatments. Curt Opin Clin Nutr Metab Care, 2012, 15:99-106.
  • 3Siddiqui RA, Shaikh SR, Sech LA, et al. Omega 3-fatty acids: health benefits and cellular mechanisms of action. Mini Rev Med Chem, 2004, 4:859-871.
  • 4Cathcart MC, Lysaght J, Pidgeon GP. Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention. Cancer Metastasis Rev, 2011, 30:363-385.
  • 5Kang JX, Wang J. A simplified method for analysis of polyunsaturated fatty acids. BMC Biochem, 2005, 6:5.
  • 6马大烈,白辰光.免疫组织化学阳性标记结果的观察和判断[J].临床与实验病理学杂志,2003,19(5):557-559. 被引量:53
  • 7Gatenby RA, Gillies RJ. A microenvironmental model of carcinogenesis. Nat Rev Cancer, 2008, 8:56-61.
  • 8Albini A, Spore MB. The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer, 2007, 7 : 139-147.
  • 9Walker WA, Blackburn G. Symposium introduction : nutrition and gene regulation. J Nutr, 2004, 134:2434S-2436S.
  • 10杨凯,田文,李红.结直肠癌组织脂肪酸及与相关肿瘤因子的分析[J].中华肿瘤防治杂志,2012,19(17):1331-1334. 被引量:8

二级参考文献62

  • 1杨玲,李连弟,陈育德,D.M.Parkin.中国2000年及2005年恶性肿瘤发病死亡的估计与预测[J].中国卫生统计,2005,22(4):218-221. 被引量:337
  • 2张思维,陈万青,孔灵芝,李连弟,鲁凤珠,李光琳,孟佳,赵平.中国部分市县1998~2002年恶性肿瘤的发病与死亡[J].中国肿瘤,2006,15(7):430-448. 被引量:171
  • 3李连弟,鲁凤珠.1990—1992年中国恶性肿瘤死亡流行分布情况分析[J].中华肿瘤杂志,1996,18(6):403-407. 被引量:227
  • 4American Cancer Society. Global Cancer Facts & Figures 2007 [M]. Atlanta, GA: American Cancer Society, 2007:12-13.
  • 5Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985 [J]. Int J Cancer, 1993,54 (4) : 594-606.
  • 6Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990 [J]. Int J Cancer, 1999, 80(6) : 827-841.
  • 7Pisani P, Parkin DM, Bray F, et al. Estimates of the worldwide mortality from 25 major cancers in 1990 [J]. Int J Caner, 1999,83(1):18-29.
  • 8Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002 [J]. CA Cancer J Clin, 2005,55(2):74-108.
  • 9Kuriki K, Tajima K. The increasing incidence of colorectal cancer and the preventive strategy in Japan [J]. Asian Pac J Cancer Prey, 2006,7(3) :495-501.
  • 10Quinn MJ. Cancer trends in United States-a view from Europe [J]. J Natl Cancer Inst, 2003,95(17) : 1258-1261.

共引文献213

同被引文献22

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部